Latest Headlines
-
ARUP Laboratories Expands AI-Augmented Parasitology Screening Tool, Improves Detection And Diagnosis
3/6/2025
ARUP Laboratories announced today the expansion of its groundbreaking AI-augmented screening tool for the detection of human gastrointestinal parasites to include wet-mount slides.
-
Savara Announces U.S. Launch Of The aPAP ClearPath Dried Blood Spot Test To Detect Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
3/6/2025
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the launch of the aPAP ClearPath Dried Blood Spot (DBS) Test in the U.S., an evolution of the first serum-based assay the Company launched.
-
Newly-Formed Archerfish Precision Diagnostics Pte Ltd: Ushers A New Era In Advanced Diagnostics
3/6/2025
In a significant development for the clinical diagnostics landscape in Singapore, Angsana Molecular & Diagnostics Laboratory (Angsana) and Pathnova Laboratories (Pathnova) have announced their merger to form Archerfish Precision Diagnostics Private Limited (Archerfish).
-
Breakthrough CRISPR-Based Test Offers Faster, More Accurate Diagnosis For Fungal Pneumonia
3/5/2025
Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii pneumonia (PJP) — a life-threatening fungal infection primarily affecting children and immunocompromised patients — more quickly and less invasively, according to a new study published in the Journal of Clinical Investigation.
-
Epredia Receives U.S. FDA 510(K) Clearance For The E1000 Dx Digital Pathology Solution Designed To Improve Laboratory Workflow In Cancer Diagnostics
3/4/2025
Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation today announced U.S. Food and Drug Administration (FDA) 510(K) clearance for its E1000 Dx Digital Pathology Solution (E1000 Dx).
-
Synergy Laboratories Introduces AI-Driven Digital Cytology Platform To Advance Cervical Cancer Screening
3/4/2025
Synergy Laboratories, a leading full-service diagnostic laboratory, has launched Hologic's state-of-the-art Genius™ Digital Diagnostics System with GeniusTM Cervical AI algorithm marking a significant advancement in cervical cancer screening and diagnostics.
-
Bio-Techne Launches New Panel Resolving Hard-To-Decipher Carrier Screening Genes
3/3/2025
Bio-Techne Corporation (NASDAQ: TECH) today announced that Asuragen, a Bio-Techne brand, has teamed up with Oxford Nanopore Technologies to launch the AmplideX® Nanopore Carrier Plus Kit, a new genetic panel and supporting analysis software for carrier screening research.
-
Sysmex America Expands Line Of 3-Part Differential Automated Hematology Analyzers With XQ-320
3/3/2025
Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, today announced the expansion of its 3-part differential automated hematology analyzer line with the XQ-320™ for reliable and accurate CBC testing.
-
Wren Laboratories Announces Discontinuation Of NETest 1.0 In Favor Of Advanced NETest 2.0
3/3/2025
Wren Laboratories, a leader in liquid biopsy diagnostics, confirms the official discontinuation of the original NETest 1.0, which has been replaced by the cutting-edge NETest 2.0.
-
LabVantage Solutions Unveils Version 8.9 Of Its Industry-Leading LIMS Platform To Improve Lab Productivity And Efficiency
3/3/2025
LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, today announced the release of LabVantage 8.9, the latest iteration of its flagship laboratory information management system (LIMS), to deliver the most cutting-edge capabilities to laboratories worldwide.